AIMMAX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 Feb 2024)
What this means for you
Registered since 27 Feb 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87158039
- Registration number
- 5413771
- Mark type
- Stylized text
- Filed
- 01 Sept 2016
- Published for opposition
- 09 May 2017
- Registered
- 27 Feb 2018
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Research and development in the fields of pharmaceuticals, drug products, biologics, [ antibodies, vaccines ] and therapeutics for the treatment and prevention of diseases
Owner
- AimMax Therapeutics, Inc., Durham, NC, US
- AimMax Therapeutics, Inc., Chapel Hill, NC, US
- AimMax Therapeutics, Inc., Chapel Hill, NC, US
Prosecution history
- 09 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 27 Feb 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Oct 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Oct 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Feb 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Jan 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jan 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Jan 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2017 — USE AMENDMENT FILED
- 11 Jan 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Dec 2017 — TEAS STATEMENT OF USE RECEIVED
- 04 Jul 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT